Solidarity Trial Vaccine Study
Title:
Solidarity Trial Vaccines: An international randomized trial of candidate vaccines against SARS-CoV-2 (COVID-19)
Purpose:
To coordinate a prompt, efficient, and reliable evaluation of the many preventive candidate SARS-CoV-2 vaccines under development
Objective:
To assess the safety and efficacy of the preventive candidate SARS-CoV-2 vaccines and to identify those that are likely to be appropriate for deployment to influence the course of the pandemic
Design:
Randomized Controlled Clinical Trial
Population:
Individuals (all gender) 16 years and above
Coverage:
Kisumu County
Site:
Kenya Impact Research and Development Organization Clinical Research Site (K- IRDO-CRS)
Duration:
1 ½ year
Funding:
World Health Organization through Kenya Aids Vaccine Initiative (KAVI) Institute of Clinical Research
Local IRB Approval:
Kenyatta National Hospital/University of Nairobi Ethics Review Committee – P258/03/2022